Finfeed Archived Mar 24, 2020
The $9.9 million capped Australian-listed Creso Pharma Limited (ASX: CPH) is set to release CBD hemp teas in Q3 2020
Next Investors Archived Mar 24, 2020
Creso Pharma Limited (ASX: CPH) is expanding its available product line with the release of a hemp tea in Q3 2020.
Get expert stock analysis direct in your inbox
Join OurMailing List